Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(10 sites)
United States
Rush University Medical Center, Chicago, Illinois Massachusetts General Hospital, Boston, Massachusetts Dana-Farber Cancer Institute, Boston, Massachusetts Mayo Clinic, Rochester, Minnesota Washington University School of Medicine Siteman Cancer Center West County, Creve Coeur, Missouri Washington University School of Medicine Siteman Cancer Center South County, St Louis, Missouri Roswell Park Cancer Institute, Buffalo, New York Duke University, Durham, North Carolina MD Anderson Cancer Center, Houston, Texas University of Utah, Salt Lake City, Utah